Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $240
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $238 to $240.
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $238 to $240.